Skip to Main Content

Paper Details

APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease.
bioRxiv
2
2023
A, APOE 2, APOE 2 allele, APOE 4, APOE2, APOE4, APP, Alzheimer disease, ApoE2, PS1, ependymal cells, human, microglial, mouse, neurodegeneration, neurodegenerative synaptic loss, neuroinflammation, patients, plaque, risk 4 allele

Datasets

Release 1.2